z-logo
open-access-imgOpen Access
Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation
Author(s) -
Angela M. Bengtson,
Brian W. Pence,
Matthew J. Mimiaga,
Bradley N. Gaynes,
Richard D. Moore,
Katerina Christopoulos,
Conall O’Cleirigh,
David J. Grelotti,
Sonia Napravnik,
Heidi M. Crane,
Michael J. Mugavero
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy496
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , sida , viral disease , virology , immunopathology , lentivirus , depression (economics) , immunology , intensive care medicine , viral load , economics , macroeconomics
The effect of depressive symptoms on progression through the human immunodeficiency virus (HIV) treatment cascade is poorly characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom